These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10783073)
1. Improved synthesis of paroxetine hydrochloride propan-2-ol solvate through one of metabolites in humans, and characterization of the solvate crystals. Sugi K; Itaya N; Katsura T; Igi M; Yamazaki S; Ishibashi T; Yamaoka T; Kawada Y; Tagami Y; Otsuki M; Ohshima T Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):529-36. PubMed ID: 10783073 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and ligand binding of tropane ring analogues of paroxetine. Keverline-Frantz KI; Boja JW; Kuhar MJ; Abraham P; Burgess JP; Lewin AH; Carroll FI J Med Chem; 1998 Jan; 41(2):247-57. PubMed ID: 9457247 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of the major metabolites of paroxetine. Segura M; Roura L; de la Torre R; Joglar J Bioorg Chem; 2003 Jun; 31(3):248-58. PubMed ID: 12818234 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter. Chudzik J; McCarthy D; Bakish D; Ravindran A; Hrdina PD Biochem Pharmacol; 1995 Oct; 50(8):1211-5. PubMed ID: 7488236 [TBL] [Abstract][Full Text] [Related]
9. Vibrational circular dichroism spectroscopy study of paroxetine and femoxetine precursors. Urbanová M; Setnicka V; Bour P; Navrátilová H; Volka K Biopolymers; 2002; 67(4-5):298-301. PubMed ID: 12012452 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for recognition of diverse antidepressants by the human serotonin transporter. Coleman JA; Gouaux E Nat Struct Mol Biol; 2018 Feb; 25(2):170-175. PubMed ID: 29379174 [TBL] [Abstract][Full Text] [Related]
11. The chemical fate of paroxetine metabolites. Dehydration of radicals derived from 4-(4-fluorophenyl)-3-(hydroxymethyl)piperidine. Šakić D; Achrainer F; Vrček V; Zipse H Org Biomol Chem; 2013 Jul; 11(25):4232-9. PubMed ID: 23680901 [TBL] [Abstract][Full Text] [Related]
12. Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers. Rannversson H; Andersen J; Bang-Andersen B; Strømgaard K ACS Chem Biol; 2017 Oct; 12(10):2558-2562. PubMed ID: 28910072 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement product. Runyon SP; Burgess JP; Abraham P; Keverline-Frantz KI; Flippen-Anderson J; Deschamps J; Lewin AH; Navarro HA; Boja JW; Kuhar MJ; Carroll FI Bioorg Med Chem; 2005 Apr; 13(7):2439-49. PubMed ID: 15755646 [TBL] [Abstract][Full Text] [Related]
14. Structural and functional analysis of g protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog. Homan KT; Wu E; Wilson MW; Singh P; Larsen SD; Tesmer JJ Mol Pharmacol; 2014 Feb; 85(2):237-48. PubMed ID: 24220010 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter. Davis BA; Nagarajan A; Forrest LR; Singh SK Sci Rep; 2016 Apr; 6():23789. PubMed ID: 27032980 [TBL] [Abstract][Full Text] [Related]
16. Hydrolysis and photolysis of paroxetine, a selective serotonin reuptake inhibitor, in aqueous solutions. Kwon JW; Armbrust KL Environ Toxicol Chem; 2004 Jun; 23(6):1394-9. PubMed ID: 15376524 [TBL] [Abstract][Full Text] [Related]
17. A structural snapshot of CYP2B4 in complex with paroxetine provides insights into ligand binding and clusters of conformational states. Shah MB; Kufareva I; Pascual J; Zhang Q; Stout CD; Halpert JR J Pharmacol Exp Ther; 2013 Jul; 346(1):113-20. PubMed ID: 23633618 [TBL] [Abstract][Full Text] [Related]
18. Paroxetine hydrochloride controlled release POLYOX matrix tablets: screening of formulation variables using Plackett-Burman screening design. Jin SJ; Yoo YH; Kim MS; Kim JS; Park JS; Hwang SJ Arch Pharm Res; 2008 Mar; 31(3):399-405. PubMed ID: 18409056 [TBL] [Abstract][Full Text] [Related]
19. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1. Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Koch DJ; Nelson DL; Wainscott DB; Ahmad LJ; Shaw J; Threlkeld PG; Wong DT Bioorg Med Chem Lett; 2003 Jun; 13(11):1903-5. PubMed ID: 12749894 [TBL] [Abstract][Full Text] [Related]
20. Highly diastereoselective and enantioselective carbon-carbon bond formations in conjugate additions of lithiated N-Boc allylamines to nitroalkenes: enantioselective synthesis of 3,4- and 3,4,5-substituted piperidines including (-)-paroxetine. Johnson TA; Curtis MD; Beak P J Am Chem Soc; 2001 Feb; 123(5):1004-5. PubMed ID: 11456647 [No Abstract] [Full Text] [Related] [Next] [New Search]